Table 1.

Effect of EPO on the values of fasting insulin, fasting blood glucose, and body weight gain of diabetic rats

Parameters	C	D	D + EPO	EPO
Insulin (pmol/l)	83 ± 1.4	32.8± 1.9 a****	63.6 ± 5.7 a**,b****	87 ± 0.71 b****
FBG (mg/dl)	94.00 ± 0.84	420.8 ± 5.07 a****	105.2 ±1.59 b****	81.8 ±1.39 a*,b****
Initial body weight (g)	196.5 ± 4.39	195 ± 2.46	194 ±3.12	195.2 ±4.31
Final body weight (g)	234.8 ± 1.2	199.6 ± 0.52 a****	206.4 ±1.03 a****	229 ±2.37

Each row represents M± SE (n=8). The letters ^a and ^b indicate significant differences when compared with the control and diabetes groups, respectively. *P<0.05, **P<0.01, and ****P<0.0001. C: Control rats; D: Diabetic rats; D + EPO: Diabetic rats that were given EPO; EPO: Non-diabetic rats subjected to EPO; FBG: Fasting blood glucose